Biohaven Ltd. (BHVN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NYSE
Market Cap: $2.09B
Last updated: Nov 17, 2026 at 11:04 AM ET
Biohaven Ltd. (BHVN) Competitors
The companies most similar to Biohaven are Harmony Biosciences Holdings (HRMY), Trevi Therapeutics (TRVI) and Beam Therapeutics (BEAM). By market cap, Biohaven ranks 5th of the 13 companies on this page; Legend Biotech (LEGN) is the largest at $3.39B.
Peer Comparison
BHVN's ROIC of -315.9% is below the peer median of -28.3%, and its revenue growth of 0.0% is below the median of 4.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Biohaven (BHVN) | $2.09B | N/A | N/A | 0.0% | -315.9% | 0.0% | 0.00% |
| Harmony Biosciences Holdings (HRMY) | $1.98B | 9.6x | 1.9x | 18.0% | 13.7% | 12.3% | 0.00% |
| Trevi Therapeutics Inc (TRVI) | $1.95B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Nuvation Bio Inc (NUVB) | $1.41B | N/A | 6.7x | -67.4% | -18.7% | 242.6% | 0.00% |
| Zenas BioPharma, Inc. Common Stock (ZBIO) | $1.90B | N/A | 168.0x | 0.0% | -104.3% | -100.0% | 0.00% |
| Pharvaris BV (PHVS) | $2.36B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vir Biotechnology Inc (VIR) | $1.71B | N/A | 5.4x | -61.0% | N/A | 19582.0% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Vor Biopharma Inc (VOR) | $1.19B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Ultragenyx (RARE) | $1.64B | N/A | 2.2x | -71.8% | N/A | 8.1% | 0.00% |
| Denali Therapeutics Inc (DNLI) | $3.00B | N/A | 159.3x | 0.0% | N/A | -100.0% | 0.00% |
| Maravai Lifesciences Holdings Inc (MRVI) | $1.96B | N/A | 5.2x | -30.8% | -28.3% | 10.1% | 0.00% |
| Peer median | $1.95B | 138.0x | 5.4x | -0.0% | -28.3% | 4.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Biohaven, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Harmony Biosciences Holdings (HRMY) | Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. | HRMY competitors |
| Trevi Therapeutics Inc (TRVI) | Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the development and commercialization of Haduvio to treat serious... | TRVI competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Nuvation Bio Inc (NUVB) | Nuvation Bio Inc., a clinical-stage biopharmaceutical company, is focused on developing therapeutic candidates for oncology. | NUVB competitors |
| Zenas BioPharma, Inc. Common Stock (ZBIO) | Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based... | ZBIO competitors |
| Pharvaris BV (PHVS) | Pharvaris NV, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies. | PHVS competitors |
| Vir Biotechnology Inc (VIR) | Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. | VIR competitors |
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Vor Biopharma Inc (VOR) | Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients. | VOR competitors |
| Ultragenyx (RARE) | Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development... | RARE competitors |
| Denali Therapeutics Inc (DNLI) | Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. | DNLI competitors |
| Maravai Lifesciences Holdings Inc (MRVI) | Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines... | MRVI competitors |
Frequently Asked Questions About BHVN
Who are Biohaven's main competitors?
The companies most similar to Biohaven include Harmony Biosciences Holdings (HRMY), Trevi Therapeutics (TRVI), Beam Therapeutics (BEAM), Nuvation Bio (NUVB) and Zenas BioPharma, Inc. Common Stock (ZBIO), listed from the closest match.
Who is Biohaven's biggest competitor?
Legend Biotech (LEGN) is the largest of the similar companies at $3.39B; Harmony Biosciences Holdings (HRMY) is the closest match by business profile, size, sector and industry.
How does BHVN stock compare with its competitors?
BHVN's net margin is 0.0% against a peer median of -0.0%.
Which of Biohaven's competitors pays a higher dividend?
Biohaven pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Biohaven bigger than its competitors?
No. Biohaven is 5th by market cap among the 13 companies on this page; the largest is Legend Biotech (LEGN) at $3.39B.
BHVN pages: Overview, Earnings, Forecast, Financials, Competitors